# ATG Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atg-biotechnology-co

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Website: www.atgbiotechnology.com
- Latest round: Angel (Oct 2, 2021)
- Investors on record: 1

## About

Established in 2018 and based in Nanjing, China, ATG Biotechnology Co., Ltd. operates as a manufacturer of biological enzymes that engaged in the research and development, production and application of raw enzymes. The company set up a production base in Nanjing and a branch office in Shanghai. Professor Zhaoxin Lu of Nanjing Agricultural University is the chief scientist of ATG Biotechnology. Some universities, such as Nanjing Agricultural University, Shanghai Jiao Tong University, Sun Yat-Sen University, and Illinois, have cooperated with ATG. In September 2019, the company was awarded the title of Jiangsu Province Science and Technology Small and Medium-sized Enterprise. In May 2023, ATG Biotechnology completed a series A funding.

The products can be categorized into three categories which are biological reagents, diagnostic materials and enzymes for mRNA vaccines. Products within include PCR series, fluorescent quantitative PCR series, cloning/point mutation series reverse transcription series, nucleic acid extraction and purification series, RT-qPCR detection platform and isothermal amplification detection platform biochemical detection platform. The company also possesses technologies such as enzyme gene modification, advanced protein engineering and large-scale protein fermentation post-processing processes, providing a total raw material-reagent solution.

## Funding rounds

- Angel, Oct 2, 2021 — Dynamic Capital

## Investors

- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Angel